Rescue of α-synuclein cytotoxicity by insulin-like growth factors (original) (raw)
alpha -Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells. ABOLISHMENT BY 6-HYDROXYDOPAMINE AND IMPLICATION FOR PARKINSON'S DISEASE
ROBERTO FERREIRA
Journal of Biological Chemistry, 2002
View PDFchevron_right
Drug Targets from Genetics: Alpha-Synuclein
Karin Danzer
CNS & Neurological Disorders - Drug Targets, 2011
View PDFchevron_right
The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells
Hamid Yaqoob Qureshi
Journal of Neurochemistry, 2009
View PDFchevron_right
lpzgc synuclein biochem_11.pdf
Claudio Zannoni
View PDFchevron_right
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Michael Schlossmacher
npj Parkinson's Disease
View PDFchevron_right
-Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine-induced Caspase 3 Activation: CROSS-TALK WITH -SYNUCLEIN AND IMPLICATION FOR PARKINSON'S DISEASE
ROBERTO FERREIRA
Journal of Biological Chemistry, 2003
View PDFchevron_right
Genetic Analysis of Families with Parkinson Disease that Carry the Ala53Thr Mutation in the Gene Encoding α-Synuclein
A. Athanassiadou
The American Journal of Human Genetics, 1999
View PDFchevron_right
Can α-synuclein be targeted in novel therapies for Parkinson’s disease?
Patrik Brundin
Expert Review of Neurotherapeutics, 2011
View PDFchevron_right
Synucleins and their relationship to Parkinson?s disease
Oliver von Bohlen und Halbach
Cell and Tissue Research, 2004
View PDFchevron_right
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration HISTORIC PERSPECTIVE OF THE DISCOVERY OF ALPHA-SYNUCLEIN
Diana Lázaro
View PDFchevron_right
α-Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells
cristine Alves da Costa
Journal of Biological Chemistry, 2002
View PDFchevron_right
Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease
Zbigniew Wszolek
Parkinsonism & Related Disorders, 2013
View PDFchevron_right
Defining α-synuclein species responsible for Parkinson disease phenotypes in mice
Drake Thrasher
Journal of Biological Chemistry
View PDFchevron_right
Poster Session BP07: Neurodegenerative Diseases
farah jayman
Journal of Neurochemistry, 2008
View PDFchevron_right
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
A. Athanassiadou
Science, 1997
View PDFchevron_right
Disorders with Synuclein Pathology and Parkinsonism
Laura L Kilarski
View PDFchevron_right
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson’s disease pathogenesis
Mauro Fasano
FEBS Journal, 2010
View PDFchevron_right
Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
Anthony Adame, Klodjan Stafa, Kori Kosberg
Neuron, 2015
View PDFchevron_right
Aggregation promoting C-terminal truncation of -synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
Juan Troncoso
Proceedings of the National Academy of Sciences, 2005
View PDFchevron_right
Parkinson's disease and α-synuclein expression
Kat Gwinn
Movement Disorders, 2011
View PDFchevron_right
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Javiera Arcos
View PDFchevron_right
Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
Marc Hurlbert
Brain Research, 2000
View PDFchevron_right
α-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease
Tziona Ben-Gedalya
PLoS ONE, 2011
View PDFchevron_right
Role of sporadic Parkinson disease associated mutations A18T and A29S in enhanced alpha synuclein fibrillation and cytotoxicity
roshan love kumar
ACS chemical neuroscience, 2017
View PDFchevron_right
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
Kat Gwinn
2011
View PDFchevron_right
The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition
Rose Sharon
Journal of Biological Chemistry, 2010
View PDFchevron_right
Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease
Denise Barbut
Frontiers in Cell and Developmental Biology, 2021
View PDFchevron_right
Synoretin—A New Protein Belonging to the Synuclein Family
Andrei Surguchov
Molecular and Cellular Neuroscience, 1999
View PDFchevron_right
α-Synuclein in Parkinson’s disease: causal or bystander?
Wolfgang Jost
Journal of Neural Transmission, 2019
View PDFchevron_right